Comparison of Dual Assignment, Cadence, and Gait Speed in Alzheimer's Dementia and Healthy Geriatric Individuals

Alzheimer Dementia Clinical Trial

Official title:

Comparison of Dual Assignment, Cadence, and Gait Speed in Alzheimer's Dementia and Healthy Geriatric Individuals

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05767580
• Other study ID #: KirikkaleUniversity-FTR-SA-71
• Status: Not yet recruiting
• Start date: June 1, 2023
• Est. completion date: February 21, 2024

Study information

• Verified date: March 2023
• Source: Kirikkale University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Tests will be performed in individuals with Alzheimer's dementia to compare dual-task and gait with healthy geriatric individuals.

Description:

In this study, it was aimed to compare double assignment, cadence and walking speed in Alzheimer's Dementia and Healthy Geriatric Individuals.

Individuals who can walk independently and who are diagnosed with Alzheimer's Dementia over the age of 65 and healthy individuals will be included in the study. It will be done with 50 people who voluntarily participated in the research.

As a data collection tool; The demographics formula with patient descriptive features is the Timed Get Up and Walk test to turn off double assignment, the 2 Minute Walk Test to evaluate the advertisement, and the Footprint Method to use cadence. It will be assessed with the Mini Mental State Test and the Montreal Cognitive Assessment Test to examine discriminative units.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Est. completion date: February 21, 2024
• Est. primary completion date: February 1, 2024
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• 65 years and older,

• Who volunteered to participate in the research,

• Able to walk independently,

• He was diagnosed with Alzheimer's by a physician for the experimental group,

• Having not been diagnosed with Alzheimer's for the control group

• Individuals who have not undergone surgery in the last 6 months

• Individuals who do not have cooperation and communication problems.

Exclusion Criteria:

• Under age 65

• Individuals who do not agree to participate in the research,

• Individuals who have a disability to do physical activity,

• Individuals who have undergone an operation in the last 6 months,

• Individuals with problems of cooperation and communication

Related Conditions & MeSH terms

• Alzheimer Dementia
• Alzheimer Disease
• Dementia

Intervention

Other:
• evaluation
The Timed Get Up and Go test to assess dual-tasking, the 4m Walk Test to assess gait, and the Footprint Method to assess cadence

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Kirikkale University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Time Up Go	Timed Start and Continue Test, In the TUG test, individuals stand up from the chair, walk 3 m, walk and sit on a swivel chair. The starting position is standardized with patients feet flat on the floor and their arms resting on the chair. The person is instructed to complete the test at their own pace and as quickly as possible. The test is started with the 'start' command. It ends with him sitting back in the chair. The test is done three times. A 2-minute rest break is given between each trial. The clinician records performance with a stopwatch for each trial.	6 month
Secondary	Dual tasking	Dual tasking (DT) is an experimental neuro-physiological process that requires an individual to perform two tasks simultaneously. When the two activities are done together, the deterioration in the performance of the tasks is defined as Dual Task Deficiency. The formula "DTD = [DT - ST]/TG × 100" was used to calculate the changes in task performances and to determine the deficiency rate, and the results were interpreted proportionally.	6 month
Secondary	Footprint method	The footprint method is carried out by pouring powder in an area of 10 m. Evaluations are made in the middle area of 6 m. The subjects started walking with the left foot and the distances of the sixth, seventh and eighth steps were measured in meters.	6 month
Secondary	Two-Minute Walk Test	Two-Minute Walk Test: It is a test used to evaluate the treatment response in moderately severe heart or lung disease or to evaluate the functional capacity of the person, which is a determinant of mortality and morbidity with a one-time measurement. Reliability, validity and responsiveness of the 2-minute walk test Amy SY Leung , Kam Keung Chan , Kevin Sykes, KS Chan demonstrated in 2006 that the 2MWT is a reliable and valid test for the assessment of exercise capacity and post-rehabilitation response in patients with moderate-to-severe COPD.	6 month